215 related articles for article (PubMed ID: 30440089)
1. Progressively disrupted somatodendritic morphology in dopamine neurons in a mouse Parkinson's model.
Lynch WB; Tschumi CW; Sharpe AL; Branch SY; Chen C; Ge G; Li S; Beckstead MJ
Mov Disord; 2018 Dec; 33(12):1928-1937. PubMed ID: 30440089
[TBL] [Abstract][Full Text] [Related]
2. Dopaminergic Neurons Exhibit an Age-Dependent Decline in Electrophysiological Parameters in the MitoPark Mouse Model of Parkinson's Disease.
Branch SY; Chen C; Sharma R; Lechleiter JD; Li S; Beckstead MJ
J Neurosci; 2016 Apr; 36(14):4026-37. PubMed ID: 27053209
[TBL] [Abstract][Full Text] [Related]
3. Manganese exposure exacerbates progressive motor deficits and neurodegeneration in the MitoPark mouse model of Parkinson's disease: Relevance to gene and environment interactions in metal neurotoxicity.
Langley MR; Ghaisas S; Ay M; Luo J; Palanisamy BN; Jin H; Anantharam V; Kanthasamy A; Kanthasamy AG
Neurotoxicology; 2018 Jan; 64():240-255. PubMed ID: 28595911
[TBL] [Abstract][Full Text] [Related]
4. Progressive parkinsonism due to mitochondrial impairment: Lessons from the MitoPark mouse model.
Beckstead MJ; Howell RD
Exp Neurol; 2021 Jul; 341():113707. PubMed ID: 33753138
[TBL] [Abstract][Full Text] [Related]
5. The MitoPark Mouse - an animal model of Parkinson's disease with impaired respiratory chain function in dopamine neurons.
Ekstrand MI; Galter D
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S185-8. PubMed ID: 20082987
[TBL] [Abstract][Full Text] [Related]
6. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
[TBL] [Abstract][Full Text] [Related]
7. Conditional deletion of Ndufs4 in dopaminergic neurons promotes Parkinson's disease-like non-motor symptoms without loss of dopamine neurons.
Choi WS; Kim HW; Tronche F; Palmiter RD; Storm DR; Xia Z
Sci Rep; 2017 Mar; 7():44989. PubMed ID: 28327638
[TBL] [Abstract][Full Text] [Related]
8. Attenuated dopaminergic neurodegeneration and motor dysfunction in hemiparkinsonian mice lacking the α5 nicotinic acetylcholine receptor subunit.
Leino S; Koski SK; Hänninen R; Tapanainen T; Rannanpää S; Salminen O
Neuropharmacology; 2018 Aug; 138():371-380. PubMed ID: 29940207
[TBL] [Abstract][Full Text] [Related]
9. Cognitive dysfunction precedes the onset of motor symptoms in the MitoPark mouse model of Parkinson's disease.
Li X; Redus L; Chen C; Martinez PA; Strong R; Li S; O'Connor JC
PLoS One; 2013; 8(8):e71341. PubMed ID: 23977020
[TBL] [Abstract][Full Text] [Related]
10. Pitx3 deficiency produces decreased dopamine signaling and induces motor deficits in Pitx3(-/-) mice.
Le W; Zhang L; Xie W; Li S; Dani JA
Neurobiol Aging; 2015 Dec; 36(12):3314-3320. PubMed ID: 26363812
[TBL] [Abstract][Full Text] [Related]
11. Thiol Oxidation by Diamide Leads to Dopaminergic Degeneration and Parkinsonism Phenotype in Mice: A Model for Parkinson's Disease.
Ray A; Kambali M; Ravindranath V
Antioxid Redox Signal; 2016 Aug; 25(5):252-67. PubMed ID: 27121974
[TBL] [Abstract][Full Text] [Related]
12. Lack of Parkin Anticipates the Phenotype and Affects Mitochondrial Morphology and mtDNA Levels in a Mouse Model of Parkinson's Disease.
Pinto M; Nissanka N; Moraes CT
J Neurosci; 2018 Jan; 38(4):1042-1053. PubMed ID: 29222404
[No Abstract] [Full Text] [Related]
13. Disruption of mitochondrial complex I induces progressive parkinsonism.
González-Rodríguez P; Zampese E; Stout KA; Guzman JN; Ilijic E; Yang B; Tkatch T; Stavarache MA; Wokosin DL; Gao L; Kaplitt MG; López-Barneo J; Schumacker PT; Surmeier DJ
Nature; 2021 Nov; 599(7886):650-656. PubMed ID: 34732887
[TBL] [Abstract][Full Text] [Related]
14. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
Novikova L; Garris BL; Garris DR; Lau YS
Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
[TBL] [Abstract][Full Text] [Related]
15. CX3CR1 Disruption Differentially Influences Dopaminergic Neuron Degeneration in Parkinsonian Mice Depending on the Neurotoxin and Route of Administration.
Tristão FS; Lazzarini M; Martin S; Amar M; Stühmer W; Kirchhoff F; Gomes LA; Lanfumey L; Prediger RD; Sepulveda JE; Del-Bel EA; Raisman-Vozari R
Neurotox Res; 2016 Apr; 29(3):364-80. PubMed ID: 26403659
[TBL] [Abstract][Full Text] [Related]
16. Repulsive Guidance Molecule a (RGMa) Induces Neuropathological and Behavioral Changes That Closely Resemble Parkinson's Disease.
Korecka JA; Moloney EB; Eggers R; Hobo B; Scheffer S; Ras-Verloop N; Pasterkamp RJ; Swaab DF; Smit AB; van Kesteren RE; Bossers K; Verhaagen J
J Neurosci; 2017 Sep; 37(39):9361-9379. PubMed ID: 28842419
[TBL] [Abstract][Full Text] [Related]
17. Impaired D2 receptor-dependent dopaminergic transmission in prefrontal cortex of awake mouse model of Parkinson's disease.
Li M; Xu H; Chen G; Sun S; Wang Q; Liu B; Wu X; Zhou L; Chai Z; Sun X; Lu Y; Younus M; Zheng L; Zhu F; Jia H; Chen X; Wang C; Zhou Z
Brain; 2019 Oct; 142(10):3099-3115. PubMed ID: 31504219
[TBL] [Abstract][Full Text] [Related]
18. Electroacupuncture Promotes Recovery of Motor Function and Reduces Dopaminergic Neuron Degeneration in Rodent Models of Parkinson's Disease.
Lin JG; Chen CJ; Yang HB; Chen YH; Hung SY
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837077
[TBL] [Abstract][Full Text] [Related]
19. Loss of dopamine disrupts circadian rhythms in a mouse model of Parkinson's disease.
Fifel K; Cooper HM
Neurobiol Dis; 2014 Nov; 71():359-69. PubMed ID: 25171792
[TBL] [Abstract][Full Text] [Related]
20. Multimodal MRI Evaluation of the MitoPark Mouse Model of Parkinson's Disease.
Cong L; Muir ER; Chen C; Qian Y; Liu J; Biju KC; Clark RA; Li S; Duong TQ
PLoS One; 2016; 11(3):e0151884. PubMed ID: 27003179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]